These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 33649708)

  • 1. The pulmonary route as a way to drug repositioning in COVID-19 therapy.
    Sarcinelli MA; Martins da Silva T; Artico Silva AD; Ferreira de Carvalho Patricio B; Mendes de Paiva FC; Santos de Lima R; Leal da Silva M; Antunes Rocha HV
    J Drug Deliv Sci Technol; 2021 Jun; 63():102430. PubMed ID: 33649708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study].
    Plaze M; Attali D; Petit AC; Blatzer M; Simon-Loriere E; Vinckier F; Cachia A; Chrétien F; Gaillard R
    Encephale; 2020 Jun; 46(3S):S35-S39. PubMed ID: 32387014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary drug delivery: an effective and convenient delivery route to combat COVID-19.
    Alipour S; Mahmoudi L; Ahmadi F
    Drug Deliv Transl Res; 2023 Mar; 13(3):705-715. PubMed ID: 36260223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Repurposing: A Strategy for Discovering Inhibitors against Emerging Viral Infections.
    Dos Santos Nascimento IJ; de Aquino TM; da Silva-Júnior EF
    Curr Med Chem; 2021; 28(15):2887-2942. PubMed ID: 32787752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Review of SARS-CoV-2 and the Ongoing Clinical Trials.
    Tu YF; Chien CS; Yarmishyn AA; Lin YY; Luo YH; Lin YT; Lai WY; Yang DM; Chou SJ; Yang YP; Wang ML; Chiou SH
    Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repurposing cefuroxime for treatment of COVID-19: a scoping review of
    Durojaiye AB; Clarke JD; Stamatiades GA; Wang C
    J Biomol Struct Dyn; 2021 Aug; 39(12):4547-4554. PubMed ID: 32538276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Repurposing Strategy (DRS): Emerging Approach to Identify Potential Therapeutics for Treatment of Novel Coronavirus Infection.
    Sahoo BM; Ravi Kumar BVV; Sruti J; Mahapatra MK; Banik BK; Borah P
    Front Mol Biosci; 2021; 8():628144. PubMed ID: 33718434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing Drugs for COVID-19: An Approach for Treatment in the Pandemic.
    Khadka S; Yuchi A; Shrestha DB; Budhathoki P; Al-Subari SMM; Ziad Alhouzani TM; Anwar Butt I
    Altern Ther Health Med; 2020 Aug; 26(S2):100-107. PubMed ID: 32827400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combating COVID-19: The role of drug repurposing and medicinal plants.
    Khan SA; Al-Balushi K
    J Infect Public Health; 2021 Apr; 14(4):495-503. PubMed ID: 33743371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential Repurposing of Drugs with Anti-SARS-CoV-2 Activity in Preclinical Trials: A Systematic Review.
    Rocha YM; de Moura GA; de Oliveira JR; de Figueiredo Nicolete LD; Nicolete R
    Curr Med Chem; 2021; 28(22):4577-4585. PubMed ID: 33019921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability.
    Debnath SK; Debnath M; Srivastava R; Omri A
    Expert Rev Anti Infect Ther; 2022 Sep; 20(9):1187-1204. PubMed ID: 35615888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delivering Benefits at Speed Through Real-World Repurposing of Off-Patent Drugs: The COVID-19 Pandemic as a Case in Point.
    Rogosnitzky M; Berkowitz E; Jadad AR
    JMIR Public Health Surveill; 2020 May; 6(2):e19199. PubMed ID: 32374264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repositioning of Drugs to Counter COVID-19 Pandemic - An Insight.
    Akilesh SM; J R; Palanisamy D; Wadhwani A
    Curr Pharm Biotechnol; 2021; 22(2):192-199. PubMed ID: 32867651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Strategies of Antiviral Drug Discovery for COVID-19.
    Mei M; Tan X
    Front Mol Biosci; 2021; 8():671263. PubMed ID: 34055887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of histone deacetylase inhibitors: A promising strategy to combat pulmonary fibrosis promoted by TGF-β signalling in COVID-19 survivors.
    P KM; Sivashanmugam K; Kandasamy M; Subbiah R; Ravikumar V
    Life Sci; 2021 Feb; 266():118883. PubMed ID: 33316266
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
    OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Anatomy of the SARS-CoV-2 Biomedical Literature: Introducing the CovidX Network Algorithm for Drug Repurposing Recommendation.
    Gates LE; Hamed AA
    J Med Internet Res; 2020 Aug; 22(8):e21169. PubMed ID: 32735546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug repurposing approach to combating coronavirus: Potential drugs and drug targets.
    Xu J; Xue Y; Zhou R; Shi PY; Li H; Zhou J
    Med Res Rev; 2021 May; 41(3):1375-1426. PubMed ID: 33277927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential of drug repositioning as a short-term strategy for the control and treatment of COVID-19 (SARS-CoV-2): a systematic review.
    Lima WG; Brito JCM; Overhage J; Nizer WSDC
    Arch Virol; 2020 Aug; 165(8):1729-1737. PubMed ID: 32514689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.